Comparable efficacy and less toxicity of pegylated liposomal doxorubicin versus epirubicin for neoadjuvant chemotherapy of breast cancer: a case-control study
Minjun Dong,1 Liang Luo,2 Xiaogang Ying,3 Xianqiu Lu,3 Jianguo Shen,1 Zhinong Jiang,4 Linbo Wang1 1Department of Surgical Oncology, 2Department of Gastroenterology, Sir Run Run Shaw Hospital, 3Zhejiang University School of Medicine, Hangzhou, People’s Republic of China; 4Department of Pat...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-07-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/comparable-efficacy-and-less-toxicity-of-pegylated-liposomal-doxorubic-peer-reviewed-article-OTT |